{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Bhimraj A"],"pubmed_abstract":["<h4>Background</h4>There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials.<h4>Objective</h4>Develop evidence-based, rapid, living guidelines intended to support patients, clinicians, and other healthcare professionals in their decisions about treatment and management of patients with COVID-19.<h4>Methods</h4>In March 2020, the Infectious Diseases Society of America (IDSA) formed a multidisciplinary guideline panel of infectious disease clinicians, pharmacists, and methodologists with varied areas of expertise to regularly review the evidence and make recommendations about the treatment and management of persons with COVID-19. The process used a living guide"],"journal":["Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"],"pagination":["ciac724"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9494372"],"repository":["biostudies-literature"],"pubmed_title":["Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19."],"pmcid":["PMC9494372"],"pubmed_authors":["Cheng VCC","Shafer RW","Edwards KM","Baden L","Falck-Ytter Y","O'Horo JC","Murad MH","Muller WJ","Nakamura MM","Gallagher JC","Bhimraj A","Shoham S","Gandhi RT","Shumaker AH","Mustafa RA","Morgan RL","Sultan S"],"additional_accession":[]},"is_claimable":false,"name":"Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.","description":"<h4>Background</h4>There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials.<h4>Objective</h4>Develop evidence-based, rapid, living guidelines intended to support patients, clinicians, and other healthcare professionals in their decisions about treatment and management of patients with COVID-19.<h4>Methods</h4>In March 2020, the Infectious Diseases Society of America (IDSA) formed a multidisciplinary guideline panel of infectious disease clinicians, pharmacists, and methodologists with varied areas of expertise to regularly review the evidence and make recommendations about the treatment and management of persons with COVID-19. The process used a living guide","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-05T10:45:38.98Z","creation":"2025-02-19T03:57:52.055Z"},"accession":"S-EPMC9494372","cross_references":{"pubmed":["36063397"],"doi":["10.1093/cid/ciac724"]}}